良性妇科疾病子宫切除术手术等待时间的影响
该回顾性队列研究纳入2012至2018年因良性疾病行子宫切除术的277例患者,按手术等待时间>30天或≤30天分组。等待>30天组患者 interim 医疗使用增加(65% vs 25%,OR 5.55,95%CI 3.27-9.41),控制混杂后再次入院风险为≤30天组的3.22倍(95%CI 1.27-8.19)。手术并发症无显著差异,但作者认为需针对脆弱人群优化围手术期协调。
要点
- 等待>30天组医疗使用增加(65% vs 25%,OR 5.55)。
- 控制混杂后,等待>30天组再次入院风险为≤30天组的3.22倍。
- 术中及术后并发症两组无显著差异。
核心结论
- 良性子宫切除术等待>30天与 interim 医疗使用增加相关;虽不增加手术并发症,但再次入院风险可能更高。
研究设计与样本
- 回顾性队列研究,纳入2012至2018年城市学术三级医疗中心因良性疾病行子宫切除术的277例患者。
- 按手术等待时间分为>30天组(106例,38.3%,中位47天,范围24-68天)和≤30天组(171例,67.1%,中位19天,范围12-26天)。
主要发现
- >30天组医疗使用增加:69/106(65%)vs 43/171(25%),OR 5.55,95%CI 3.27-9.41。
- 术中并发症:9/106(8%)vs 19/171(11%),P=0.482;术后并发症:28/106(26%)vs 32/171(19%),P=0.13。
- 控制混杂后,>30天组再次入院风险为≤30天组的3.22倍,95%CI 1.27-8.19。
临床怎么用
- 作者认为,需要针对良性子宫切除术患者尤其是脆弱人群优化围手术期协调的干预措施,以改善医疗质量、减少冗余低效的医疗使用和不必要延迟。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To determine the impact of surgical wait time on healthcare use and surgical outcomes for patients undergoing hysterectomy for benign gynecologic indications. DESIGN: Retrospective cohort study. SETTING: Urban, academic tertiary care center. PATIENTS: Patients who underwent hysterectomy for benign disease between 2012 and 2018. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were categorized into 2 groups, dichotomized by surgical wait times >30 days or ≤30 days. Healthcare use was measured by the number of discrete patient interactions with the healthcare system through phone calls, secure electronic messaging, and office and emergency room visits. Univariate and multivariable logistic regression models were performed to assess the association between surgical wait time and healthcare use and perioperative outcomes while controlling for confounders. A total of 277 patients were included in our analysis: 106 (38.3%) had surgical wait times >30 days (median 47 days, range 24-68 days), and 171 (67.1%) had surgical wait times ≤30 days (median 19 days; range 12-26 days). The groups did not differ by age, insurance status, substance use, or comorbid conditions. Patients in the group with surgical wait times >30 days were more likely to have increased healthcare use (69 of 106, 65% vs 43 of 171, 25%; odds ratio 5.55; 95% confidence interval, 3.27-9.41). There were no differences in intraoperative complications (9 of 106, 8% vs 19 of 171, 11%; p = .482) or postoperative complications (28 of 106, 26% vs 32 of 171, 19%; p = .13) between the groups; however, after controlling for potential confounders, patients with surgical wait times >30 days were 3.22 times more likely to be readmitted than patients with surgical wait times ≤30 days (95% confidence interval, 1.27-8.19). CONCLUSION: A surgical wait time >30 days in patients undergoing a hysterectomy for benign disease is associated with increased healthcare use in the interim. Although patients who experience longer surgical wait times do not experience worse surgical outcomes, they may be at higher risk for readmission after surgery. Targeted interventions to optimize perioperative coordination of care for patients undergoing a hysterectomy for benign disease, especially those within vulnerable populations, are needed to improve quality of care, decrease any redundant or inefficient healthcare use, and reduce any unnecessary delays.
引用
- Traylor J, Koelper N, Kim SW, et al. Impact of Surgical Wait Time to Hysterectomy for Benign Gynecologic Disease. J Minim Invasive Gynecol. 2020. PMID: 32891825. doi:10.1016/j.jmig.2020.08.486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。